Answer
Efavirenz can cause late-onset neurotoxicity, including ataxia and encephalopathy with impaired consciousness, confusion, psychomotor slowing, psychosis or delirium, months to years after starting treatment.
Sources for this answer
- Efavirenz 600 mg film-coated tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.4 Special warnings and precautions for use · Version 12Document updated
Sources checked